RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...

Advantage plans do a better job than standalone Part D policies, albeit with important gap ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

A private donation from Sally Cahill, USA, to researchers at Karolinska Institutet could make a new treatment for severe rheumatoid arthritis a ...

BITS Pilani's new nanomedicine gel shows promising preclinical results for rheumatoid arthritis treatment, enhancing drug delivery and reducing inflammation.

ELV001 aiming to disrupt the treatment paradigm for patients with incomplete response to standard of care (methotrexate + TNF inhibitors)Phase 2b trial enrolling approximately 180 patients across nine ...

Morning stiffness from rheumatoid arthritis can make it hard to get going. Try this morning routine to start your day right.

A macrophage-targeted PET/CT tracer predicts anti-TNF response in rheumatoid arthritis at baseline and four weeks, enabling ...

Elevara Medicines has dosed the first patient in its phase 2b START-SYNERGY trial, marking a key step in the development of ELV001, an oral CDK4/6 inhibitor being studied for rheumatoid arthritis in ...

A widely used treatment for rheumatoid arthritis may offer an unexpected cardiovascular benefit. Methotrexate has been a staple treatment for rheumatoid arthritis for decades, valued for its ability ...

KT501 is engineered to target a broad spectrum of B-cell populations, including plasma cells, by simultaneously binding to CD19 and BCMA. Unlike traditional B-cell therapies, KT501 is designed to ...